NCT00638508View on ClinicalTrials.gov

ON-Q Pump Infusion of Ketorolac and Ropivacaine at the Wound Site for Postoperative Pain Management

PHASE4CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Postoperative Pain
Interventions
DRUG

Ketorolac

Patients will receive Ketorolac at 5 mg/hr not to exceed 120 mg/day

DRUG

Ketorolac and Ropivacaine

Patients will receive Ketorolac at 5 mg/hr plus 0.5% Ropivacaine

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

Sponsors
All Listed Sponsors
collaborator

I-Flow

INDUSTRY

lead

Maimonides Medical Center

OTHER